He explained: "With the clocks set to go back at the end of March, bringing longer days and shorter nights, people with dementia may struggle to distinguish between 6am and 6pm.

Kosuke Inoue, M.D., Ph.D., from Kyoto University in Japan, and colleagues compared the effect of GLP-1 RAs to DPP4is as second-line therapy for type 2 diabetes on the risk of dementia in a target ...